Withdrawal of shares - Dose Daily : Pharma News | Latest Pharmaceutical News, Research & Updates

Dose Daily News is your trusted source for the latest updates in healthcare and pharmaceuticals. We deliver clear, reliable, and timely news to keep you informed and ahead in the world of health and medicine.

Latest news

Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats

Breaking News June 15, 2026 0

Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the...

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

Breaking News June 14, 2026 0

The Central Drugs Standard Control Organisation (CDSCO), under the...

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

Breaking News June 14, 2026 0

The U.S. Food and Drug Administration has granted accelerated...

The FDA has outlined its updated strategy for generic drug oversight

Breaking News June 14, 2026 0

The U.S. Food and Drug Administration (FDA) announced its...

Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis

Breaking News June 12, 2026 0

In a decisive move to counter critical domestic medicine...

Kerala on High Alert as Shigella Outbreak Spreads; ‘Operation Clean Kerala’ Intensified

Dose daily June 13, 2026 0

Kerala has declared a health alert following a surge...

Tag: Withdrawal of shares

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

The FDA has outlined its updated strategy for generic drug oversight

Orionis Biosciences Announces $1.44B Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines

Dr. Sharadwat Mukherjee Takes Charge as West Bengal Health Minister, Sets Vision for Modern, Equitable Healthcare

Follow us

Categories

Latest news

Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

Popular news

The FDA has outlined its updated strategy for generic drug oversight

Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis

Kerala on High Alert as Shigella Outbreak Spreads; ‘Operation Clean Kerala’ Intensified